ArticleFoods (Basel, Switzerland)2025
Sustainable Extraction and Multimodal Characterization of Fungal Chitosan from
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Natural Biomaterials for Osteochondral Repair: From Source to Strategy.Advanced healthcare materials · 2026Review
- Simultaneous synthesis of hydroxyapatite/chitosan composite from crab shells and its polycaprolactone-blended scaffolds for enhanced bone regeneration.RSC advances · 2025Article
- Article
- Fungal-Derived Chitosan fromMaterials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biologically derived polymers, such as chitosan, have gained attention as sustainable alternatives to synthetic materials for food and biomedical applications. Fungal-derived chitosan offers notable advantages over crustacean-based chitosan, including a renewable origin and lower allergenic potential. In this study, chitosan was extracted from fungal biomass through a sequential process comprising demineralization, deproteinization, and deacetylation. The extracted material was characterized using Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), scanning electron microscopy (SEM), zeta potential measurement, dynamic light scattering (DLS), and color analysis. Compared to commercial chitosan, the fungal chitosan exhibited lower crystallinity and thermal stability, as well as a more porous surface morphology. Its degree of deacetylation and surface charge suggest promising potential for use in biodegradable films and functional materials. These findings highlight the feasibility of using fungal biomass as a sustainable and valuable source of chitosan for technological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.